A microfluidic analytical system for monitoring an analyte (for example, glucose) in a liquid sample (e.g., ISF) includes an analysis module with at least one micro-channel for receiving and transporting a liquid sample, at least one analyte sensor for measuring an analyte in the liquid sample and at least one position electrode. The analyte sensor(s) and position electrode(s) are in operative communication with the micro-channel. The microfluidic system also includes a meter configured for measuring an electrical characteristic (such as impedance or resistance) of the position electrode(s). Moreover, the measured electrical characteristic is dependent on the position of the liquid sample in the micro-channel that is in operative communication with the position electrode for which an electrical characteristic is measured.
|
1. A microfluidic analytical system for monitoring an analyte in a liquid sample, the microfluidic analytical system comprising:
an analysis module including
at least one micro-channel for receiving and transporting a liquid sample;
at least one analyte sensor for measuring an analyte in the liquid sample, each of the at least one analyte sensors being in operative communication with a micro-channel; and
at least one position electrode, each of the at least one position electrodes in operative communication with at least one micro-channel; and
a meter configured for measuring an electrical characteristic of the at least one position electrode, the electrical characteristic being dependent on a position of the liquid sample in the micro-channel in operative communication with the at least one position electrode for which an electrical characteristic is measured.
2. The microfluidic analytical system of
3. The microfluidic analytical system of
4. The microfluidic analytical system of
5. The microfluidic analytical system of
wherein the meter is configured for measuring an electrical characteristic between the first and the second position electrode.
6. The microfluidic analytical system of
7. The microfluidic analytical system of
8. The microfluidic analytical system of
9. The microfluidic analytical system of
10. The microfluidic analytical system of
11. The microfluidic analytical system of
12. The microfluidic analytical system of
wherein the meter measures an electrical characteristic between the position electrode in the main micro-channel and either of the position electrodes in the first and second branching micro-channels.
13. The microfluidic analytical system of
wherein the meter measures an electrical characteristic between either of the two position electrodes in the first branching micro-channel and the two position electrodes in the second branching micro-channel.
14. The microfluidic analytical system of
15. The microfluidic analytical system of
|
1. Field of the Invention
The present invention relates, in general, to analytical devices and, in particular, to microfluidic analytical systems.
2. Description of the Related Art
In analytical devices based on liquid samples (i.e., fluidic analytical devices), the requisite liquid samples should be controlled with a high degree of accuracy and precision in order to obtain reliable analytical results. Such control is especially warranted with respect to “microfluidic” analytical devices that employ liquid samples of small volume, for example, 10 nanoliters to 10 microliters. In such microfluidic analytical devices, the liquid samples are typically contained and transported in micro-channels with dimensions on the order of, for example, 10 micrometers to 500 micrometers.
The control (e.g., transportation, position detection, flow rate determination and/or volume determination) of small volume liquid samples within micro-channels can be essential in the success of a variety of analytical procedures including the determination of glucose concentration in interstitial fluid (ISF) samples. For example, obtaining reliable results may require knowledge of liquid sample position in order to insure that a liquid sample has arrived at a detection area before analysis is commenced. The relatively small size of the liquid samples and micro-channels in microfluidic analytical devices can, however, render such control problematic.
In the context of analytical systems for blood glucose monitoring, continuous or semi-continuous monitoring systems and methods are advantageous in that they provide enhanced insight into blood glucose concentration trends, the effect of food and medication on blood glucose concentration and a user's overall glycemic control. A challenge of continuous or semi-continuous glucose monitoring systems is that only small volumes of liquid sample (e.g., an ISF liquid sample of about 250 nanoliters) are generally available for measuring a glucose concentration. In addition, it is difficult to transport small volumes of liquid from a target site to an ex vivo glucose monitor with a controlled flow rate and in such a way that the position and total volume of extracted fluid is known.
Still needed in the field, therefore, is a microfluidic analytical system that enables small volume liquid sample control and otherwise alleviate the problems described above.
Microfluidic analytical systems according to embodiments of the present invention enable small volume liquid sample control and otherwise alleviate the problems described above.
A microfluidic analytical system for monitoring an analyte (e.g., glucose) in a liquid sample (e.g., ISF) according to an embodiment of the present invention includes an analysis module with at least one micro-channel for receiving and transporting a liquid sample, at least one analyte sensor for measuring an analyte in the liquid sample and at least one position electrode. The analyte sensor(s) and position electrode(s) are in operative communication with the micro-channel.
The microfluidic analytical system also includes a meter configured for measuring an electrical characteristic (e.g., impedance or resistance) of the position electrode(s). For example, the meter may measure an electrical characteristic (e.g., resistance) between two ends of a single position electrode or measure an electrical characteristic (e.g., impedance) between two position electrodes.
Moreover, in embodiments of microfluidic analytical systems according to embodiments of the present invention, the measured electrical characteristic is dependent on the position of the liquid sample in the micro-channel that is in operative communication with the position electrode for which an electrical characteristic is measured. For example, a change in measured impedance can be dependent on the position of the front of a conducting liquid sample in a micro-channel with respect to one or more position electrodes.
Since microfluidic analytical devices according to embodiments of the present invention include a meter that measures an electrical characteristic that is dependent on liquid sample position in the micro-channel, the measurements enable accurate liquid sample position detection, liquid sample flow rate determination and/or liquid sample volume determination.
A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which principles of the invention are utilized, and the accompanying drawings of which:
Microfluidic analytical system 100 includes an analysis module 102 with a micro-channel 104 for receiving and transporting a liquid sample (e.g., an ISF sample extracted from a dermal tissue target site), an analyte sensor 106 (e.g., an electrochemical analyte sensor or photometric analyte sensor) for measuring an analyte (e.g., glucose) in the liquid sample, and first and second position electrodes 108 and 110. In the embodiment of
Microfluidic analytical system 100 further includes a meter 112 for measuring impedance between first position electrode 108 and second position electrode 110, with the measured impedance being dependent on the position of a liquid sample (not shown in
In general, measuring impedances, or ohmic resistances, between position electrodes in embodiments of the present invention can be accomplished by applying a voltage therebetween and measuring the resulting current. Either a constant voltage or an alternating voltage can be applied between the position electrodes and the resulting direct current (DC) or alternating current (AC), respectively, measured. The resulting DC or AC current can then be used to calculate the impedance or ohmic resistance. Furthermore, one skilled in the art will recognize that measuring an impedance can involve measuring both an ohmic drop (i.e., resistance [R] in Ohms or voltage/current) and measuring capacitance (i.e., capacitance in Farads or coulombs/volt). In practice, impedance can be measured, for example, by applying an alternating current to the position electrode(s) and measuring the resulting current. At different frequencies of alternating current, either resistive or capacitive effects prevail in determining the measured impedance. The pure resistive component can prevail at lower frequencies while the pure capacitive component can prevail at higher frequencies. To distinguish between the resistive and capacitive components, the phase difference between the applied alternating current and the measured resulting current can be determined. If there is zero phase shift, the pure resistive component is prevailing. If the phase shift indicates that the current lags the voltage, then the capacitive component is significant. Therefore, depending on the frequency of an applied alternating current and position electrode configuration, it can be beneficial to measure either resistance or a combination of resistance and capacitance.
In the embodiment of
The frequency and amplitude of the alternating voltage applied between the first and second position electrodes can be predetermined such that the presence of a liquid sample between the first and second position electrodes can be detected by a significant increase in measured current.
With respect to the measurement of impedance or resistance, the magnitude of the applied voltage can be, for example, in range from about 10 mV to about 2 volts for the circumstance of an ISF liquid sample and carbon-based or silver-based ink position electrodes. The lower and upper limits of the applied voltage range are dependent on the onset of electrolysis or electrochemical decomposition of the liquid sample. In the circumstance that an alternating voltage is employed, the alternating voltage can be applied, for example, at a frequency that results in a negligible net change in the liquid sample's properties due to any electrochemical reaction. Such a frequency range can be, for example, from about 10 Hz to about 100 kHz with a voltage waveform symmetrical around 0 Volts (i.e., the RMS value of the alternating voltage is approximately zero).
As depicted in a simplified manner in
In the embodiment of
Molded plug 114 includes an inlet channel 120 and a registration pole 122. Micro-channel disc 116 is configured to define (along with laminate layer 118) a liquid sample waste reservoir 124, as well as the aforementioned micro-channel 104 and sensor chamber 105. In addition, micro-channel disc 116 includes a registration hole 126 (see, for example,
Laminate layer 118 includes an access hole 128, a membrane valve 130, and in the embodiment of
Micro-channel 104 has cross-sectional dimensions perpendicular to a direction of fluid flow (i.e., height and width) in the range of about 10 micrometers to about 500 micrometers. Typical liquid sample volumes to be handled in a micro-channel(s) of embodiments of the present invention are on the order of about 10 nanoliters to about 10 microliters. In this respect, the term “handled” is in reference to the transportation of various liquid sample volumes including, but not limited to, isolated liquid sample volumes extracted from a target site (e.g., isolated volumes in the range of 50 nl to 250 nl), the minimum liquid sample volume required by an analyte sensor (for example, 50 nl), and the total liquid sample volume that is conducted through a micro-channel throughout the useful lifetime of a microfluidic analytical system (for example, a total volume of approximately 10 micro-liters).
Registration pole 122 of molded plug 114 is employed during manufacturing of microfluidic analytical system 100 to ensure adequate alignment (i.e., registration) of molded plug 114 and micro-channel disc 116. For example, such alignment must insure that analyte sensor 106 is operatively aligned with sensor chamber 105 and that first and second position electrodes 108 and 110 are aligned with post-sensor micro-channel channel 104b. During manufacturing, laminate layer 118 can be aligned with micro-channel disc 116 using registration features included in laminate layer 118 and/or micro-channel disc 116 (not shown) or by optical verification.
Registration hole 126 of micro-channel disc 116 is depicted as having a half circle shape and extending entirely through micro-channel disc 116. Registration pole 122 has a shape and size that are complementary to registration hole 126, thus providing for micro-channel disc 116 to securely interface with the molded plug 114, as depicted in
Although not depicted in
It is contemplated that a liquid sample (e.g., an ISF sample) will be transported to inlet channel 120 by suitable means, such as a sampling module as described below with respect to
In an embodiment of
First and second position electrodes 108 and 110, along with meter 112, can be used to determine the liquid sample position within micro-channel 104, the flow rate of a liquid sample and/or the volume of an extracted liquid sample to help control the depression of membrane valve 130. It is beneficial to determine liquid sample position in order to ascertain when a minimum amount of liquid sample has been collected into analysis module 102 to initiate analyte determination. It can also be beneficial to determine liquid sample flow rate and/or the total amount of liquid sample that has entered microfluidic analytical system 100 in order to control membrane valve 130 in a manner that facilitates semi-continuous stopped flow measurements (i.e., measurements taken with liquid sample flow momentarily halted and that result in a predetermined number of measurements per unit time [typically in the range of 4 to 10 measurements per hour] rather than a continuous measurement) over a predetermined time periods. In addition, determining liquid sample flow rate and the total amount of liquid sample enables sensor lag compensation. Furthermore, analyte sensor 106 may be sensitive to flow rate. Therefore, the use of first and second position electrodes and meter 112 allows system 100 to more accurately determine an analyte over an extended period of time such as, for example, about 8 hours.
In the embodiment of
After an analyte in a liquid sample has been determined by analyte sensor 106, the liquid sample is transported to post-sensor micro-channel portion 104b.
One skilled in the art will recognize that analyte monitoring systems according to embodiments of the present invention can be employed, for example, as a subsystem in a variety of devices. For example, embodiments of the present invention can be employed as an analysis module of system 200 depicted in
In system 200, disposable cartridge 212 includes a sampling module 218 for extracting the bodily liquid sample (namely, an ISF sample) from a body (B, for example, a user's skin layer) and an analysis module 200 for measuring an analyte (i.e., glucose) in the bodily fluid. Sampling module 218 can be any suitable sampling module known to those of skill in the art, while analysis module 220 can be a microfluidic analytical system according to embodiments of the present invention. Examples of suitable sampling modules are described in International Application PCT/GB01/05634 (published as WO 02/49507 A1 on Jun. 27, 2002) and U.S. patent application Ser. No. 10/653,023, which is hereby fully incorporated herein by reference. However, in system 200, sampling module 218 is configured to be disposable since it is a component of disposable cartridge 212.
As depicted in
During use of system 200, penetration member 222 is inserted into the target site (i.e., penetrates the target site) by operation of launching mechanism 224. For the extraction of an ISF sample from a user's skin layer, penetration member 222 can be inserted to a maximum insertion depth in the range of, for example, 1.5 mm to 3 mm. In addition, penetration member 222 can be configured to optimize extraction of an ISF sample in a continuous or semi-continuous manner. In this regard, penetration member 222 can include, for example, a 25 gauge, thin-wall stainless steel needle (not shown in
In the embodiment of
Configuration 300 can be used to determine the position or flow rate of a liquid sample in micro-channel 310. In the configuration of
Furthermore, when electrical impedance meter 306 measures a change in impedance due to the presence of a liquid sample between the first and second position electrodes, a signal can be sent to timer 308 to mark the time at which liquid is first present between the first and second position electrodes. When the measured impedance indicates that the liquid sample has reached the second position electrode, another signal can be sent to timer 308. The difference in time between when a liquid sample is first present between the first and second position electrodes and when the liquid sample reaches the second position electrode can be used to determine liquid sample flow rate (given knowledge of the volume of micro-channel 310 between the first and second position electrodes). Furthermore, knowledge of liquid sample flow rate and/or liquid sample position can be used to determine total liquid sample volume. In addition, a signal denoting the point in time at which a liquid sample arrives at second position electrode 304 can also be sent to a local controller module (e.g., local controller module 214 of
In the embodiment of
In the embodiment of
An advantage of the configuration of
Configuration 450 differs from configurations 300 and 400 in that configuration 450 includes three position electrodes. The inclusion of three position electrodes provides for an improved ability to accurately detect the position and flow rate of a liquid sample within micro-channel 464. For example, the use of two position electrodes enables the detection of a single bolus (i.e., the volume contained in a micro-channel between the two position electrodes). However, the use of three (or more) position electrodes enables the detection of multiple boluses as the liquid sample sequentially passes the three (or more) position electrodes.
Furthermore, configuration 500 includes a first analyte sensor 514 (in operative communication with first branch micro-channel 504) and a second analyte sensor 516 (in operative communication with second branch micro-channel 506), a meter 518 and timer 520. Meter 518 is configured to measure an electrical characteristic (e.g., impedance) between the first position electrode and either of the second and third position electrodes.
It is envisioned that configuration 500 will be employed in a device that includes liquid handling means for selectively directing a liquid sample from main micro-channel 502 to either of first and second branch micro-channels 504 and 506. Examples of such liquid handling means include, but are not limited to, active valves, passive valves, capillary breaks, air pressure barriers and hydrophobic patches.
Configuration 500 can be employed to detect the position of a liquid sample in either first branch micro-channel 504 (by employing meter 518 to measure an electrical characteristic between first position electrode 508 and second position electrode 510) or second branch micro-channel 506 (by employing meter 518 to measure an electrical characteristic between first position electrode 508 and third position electrode 512). Such detection(s) can be employed to control liquid sample flow and the determination of an analyte in the liquid sample by either first analyte sensor 514 or second analyte sensor 516.
Furthermore, configuration 550 includes a first analyte sensor 566 (in operative communication with first branch micro-channel 554) and a second analyte sensor 568 (in operative communication with second branch micro-channel 556), a meter 570 and timer 572. Meter 570 is configured to measure an electrical characteristic (e.g., impedance) between either of the first and second position electrodes and the third and fourth position electrodes.
It is envisioned that configuration 550 will be employed in a device that includes liquid handling means for selectively directing a liquid sample from main micro-channel 552 to either of first and second branch micro-channels 554 and 556. Examples of such liquid handling means include, but are not limited to, active valves, passive valves, capillary breaks, air pressure barriers and hydrophobic patches.
Configuration 550 can be employed to detect the position of a liquid sample in either first branch micro-channel 554 (by employing meter 570 to measure an electrical characteristic between first position electrode 558 and second position electrode 560) or second branch micro-channel 556 (by employing meter 570 to measure an electrical characteristic between third position electrode 562 and fourth position electrode 564). Such detection(s) can be employed to control liquid sample flow and the determination of an analyte in the liquid sample by either first analyte sensor 566 or second analyte sensor 568. A benefit of configuration 550 is that the first and second position electrodes (as well as the third and fourth position electrodes) can be positioned relatively close together to enable accurate measurements of relatively high electrical characteristics (e.g., relatively high impedances) therebetween.
Configuration 600 includes a first position electrode 602 and a second position electrode 604 in an interdigitated configuration. Configuration 600 also includes a micro-channel 606 and a meter 608. First and second position electrodes 602 and 604 each having a plurality of electrode portions that are placed substantially parallel to, and in alternating succession with, each other (e.g., in an alternating, “finger-like” pattern as depicted in
The position electrodes of embodiments of the present invention and the spacing therebetween can be of any suitable dimension. Advantageously, an interdigitated configuration can be employed with dimensions (e.g., dimensions Wg and We of
In configuration 600, each “finger” can independently have a width We in the range of, for example, from about 1 micrometers to about 1500 micrometers. The separation between electrode “fingers” (Wg) can be, for example, in the range between about 0.1 millimeters and about 15 millimeters. The thickness of the position electrodes is sufficient to support a desired electric current. Exemplary thicknesses are, for example, in the range from about 1 micrometers to about 100 micrometers.
Interdigitated configurations such as configuration 600 can have any number of “fingers” that are sufficient to provide utility, e.g., providing contact with a liquid sample and to measure an electrical characteristic. An interdigitated configuration can have, for example, from 2 to about 100 “fingers.”
Configuration 600 can be employed to detect a liquid sample bolus(es) flowing through micro-channel 606. With such boluses having a pre-determined volume (such as for example 250 nanoliters) defined by the height and width of micro-channel 606 and the distance Wg. For example, if micro-channel 606 has a height and width that are both about 250 microns, We is about 0.5 millimeters and Wg is about 4 millimeters, then when there is no liquid sample bridging between any finger of position electrode 602 and position electrode 604, the resistance between first electrode 602 and second electrode 604 is essentially infinity. However, if an ISF liquid sample bridges (fills) micro-channel 606 between the first finger of the first position electrode and the first finger of the second position electrode (a circumstance depicted by wavy lines in
It should be noted that in configuration 600, the resistance of each finger Re is much less than RI by at least about a factor of ten. As micro-channel 606 fills further with a liquid sample, the measured total resistance RT between first position electrode 602 and second position electrode 604 further decreases. The decrease in total measured total resistance RT can characterized by the equation
where n=the number fingers “bridged” by the liquid sample. Configuration 600 is particularly useful when Re is much less than RI.
In configuration 600, micro-channel 606 is depicted as passing (i.e., coming into operative communication with) each electrode finger 602a one time. However, micro-channel 606 could alternatively have a serpentine configuration such that micro-channel 606 passes each electrode finger 602a a plurality of times. Such a configuration can enhance the ability to easily resolve relatively small liquid sample volumes (e.g., liquid sample volumes of less than 5 nl).
Configuration 650 includes a single comb-shaped position electrode 652 with eight “fingers” 652a, a micro-channel 654 and a meter 656. Electrode fingers 652a serve to define electrode segments therebetween with each segment having a resistance Re (as depicted in
When there is no liquid sample in micro-channel 654 between any of the eight fingers 652a, a measured total resistance of position electrode 652 is the summation of the resistance for each electrode segment Re (i.e., the resistance of all electrode elements together). However, once a liquid sample begins to fill micro-channel 654 between any of fingers 652a, the measured total resistance RT decreases since resistance RI is created in parallel to Re (see
It should be noted that the dimensions Wg and We of
Configuration 750 includes a position electrode 752, micro-channel 754, bypass electrode 756, and meter 758. Position electrode 752 is a single comb-shaped position electrode with eight electrode “fingers” 752a. Electrode fingers 752a serve to define electrode segments therebetween with each segment having a resistance Re (as depicted in
In the absence of any liquid sample, bypass electrode 756 is electrically floating. However, when a liquid sample is present between two consecutive electrode fingers 752a, bypass electrode 756 becomes a part of the circuit depicted in
Assuming that Rb is significantly less than RI′ (i.e., the resistance of a liquid sample between an electrode finger and a bypass electrode), more current will flow through the bypass electrode than the liquid sample. Therefore, configuration 750 is beneficial when used in combination with high-resistive liquid samples since bypass electrode 756 effectively reduces the RT, as shown schematically in
An interdigitated configuration similar to that of
A potential waveform was applied between the first and second position electrodes with a frequency of 0.25 MHz, an amplitude of +/−0.1 volts, and a RMS of 0 volt. Based on the resulting current between the first and second position electrodes, measured total resistance RT and total measured admittance were calculated (it should be noted that AT=1/RT).
It should be understood that various alternatives to the embodiments of the invention described herein may be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that structures within the scope of these claims and their equivalents be covered thereby.
Bohm, Sebastian, Rodgers, James Iain, Stiene, Matthias, Richter, Tanja, Moffat, James, McNeilage, Alan
Patent | Priority | Assignee | Title |
10034628, | Dec 12 2005 | Sanofi-Aventis Deutschland GmbH | Low pain penetrating member |
10213140, | May 17 2013 | Johnson & Johnson Vision Care, Inc | Ophthalmic lens with a microfluidic system |
10646870, | Jun 25 2015 | CYTONOME/ST, LLC | Microfluidic device and system using acoustic manipulation |
11684920, | Jul 07 2020 | International Business Machines Corporation | Electrical tracking of a multiphase microfluidic flow |
7297151, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for body fluid sampling with improved sensing |
7316700, | Jun 12 2002 | Sanofi-Aventis Deutschland GmbH | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
7344507, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for lancet actuation |
7344894, | Oct 16 2001 | Sanofi-Aventis Deutschland GmbH | Thermal regulation of fluidic samples within a diagnostic cartridge |
7374544, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
7402616, | Sep 30 2004 | Cilag GmbH International; Lifescan IP Holdings, LLC | Fusible conductive ink for use in manufacturing microfluidic analytical systems |
7410468, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
7481776, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
7491178, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
7524293, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
7537571, | Jun 12 2002 | Sanofi-Aventis Deutschland GmbH | Integrated blood sampling analysis system with multi-use sampling module |
7547287, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
7563232, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
7582063, | Nov 21 2000 | Sanofi-Aventis Deutschland GmbH | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
7582099, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
7604592, | Jun 14 2004 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for a point of care device |
7648468, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
7665303, | Mar 31 2004 | Cilag GmbH International; Lifescan IP Holdings, LLC | Method of segregating a bolus of fluid using a pneumatic actuator in a fluid handling circuit |
7666149, | Dec 04 1997 | Sanofi-Aventis Deutschland GmbH | Cassette of lancet cartridges for sampling blood |
7674232, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
7682318, | Jun 12 2002 | Sanofi-Aventis Deutschland GmbH | Blood sampling apparatus and method |
7699791, | Jun 12 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving success rate of blood yield from a fingerstick |
7713214, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing |
7717863, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
7722809, | Jun 04 2004 | Wisconsin Alumni Research Foundation | Bioagent detection device |
7731729, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
7822454, | Jan 03 2005 | AUTO INJECTION TECHNOLOGIES LLC | Fluid sampling device with improved analyte detecting member configuration |
7833171, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
7841992, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Tissue penetration device |
7850621, | Jun 07 2004 | AUTO INJECTION TECHNOLOGIES LLC | Method and apparatus for body fluid sampling and analyte sensing |
7850622, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Tissue penetration device |
7862520, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Body fluid sampling module with a continuous compression tissue interface surface |
7874994, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
7892183, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for body fluid sampling and analyte sensing |
7901362, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
7909774, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
7909775, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
7909777, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
7909778, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
7914465, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
7938787, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
7959582, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
7976476, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Device and method for variable speed lancet |
7981055, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Tissue penetration device |
7981056, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Methods and apparatus for lancet actuation |
7988644, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
7988645, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
8007446, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
8016774, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Tissue penetration device |
8062231, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
8079960, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Methods and apparatus for lancet actuation |
8123700, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
8162853, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Tissue penetration device |
8197421, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
8197423, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
8202231, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
8206317, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Tissue penetration device |
8206319, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Tissue penetration device |
8211037, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Tissue penetration device |
8216154, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Tissue penetration device |
8221334, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
8251921, | Jun 06 2003 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for body fluid sampling and analyte sensing |
8267870, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for body fluid sampling with hybrid actuation |
8282576, | Sep 29 2004 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for an improved sample capture device |
8282577, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
8296918, | Dec 31 2003 | AUTO INJECTION TECHNOLOGIES LLC | Method of manufacturing a fluid sampling device with improved analyte detecting member configuration |
8333710, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Tissue penetration device |
8337419, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Tissue penetration device |
8337420, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Tissue penetration device |
8343075, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Tissue penetration device |
8360991, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Tissue penetration device |
8382682, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
8382683, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Tissue penetration device |
8388551, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for multi-use body fluid sampling device with sterility barrier release |
8403864, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
8414503, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Methods and apparatus for lancet actuation |
8430828, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
8435190, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
8439872, | Mar 30 1998 | Sanofi-Aventis Deutschland GmbH | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
8579831, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
8622930, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Tissue penetration device |
8641643, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Sampling module device and method |
8652831, | Dec 30 2004 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for analyte measurement test time |
8668656, | Dec 31 2003 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
8679033, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Tissue penetration device |
8690796, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
8702624, | Sep 29 2006 | AUTO INJECTION TECHNOLOGIES LLC | Analyte measurement device with a single shot actuator |
8721671, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Electric lancet actuator |
8828203, | May 20 2005 | SANOFI S A | Printable hydrogels for biosensors |
8845550, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Tissue penetration device |
8905945, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
8945910, | Sep 29 2003 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for an improved sample capture device |
8965476, | Apr 16 2010 | Pelikan Technologies, Inc | Tissue penetration device |
9034639, | Dec 30 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus using optical techniques to measure analyte levels |
9072842, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
9089294, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Analyte measurement device with a single shot actuator |
9089678, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
9144401, | Dec 12 2005 | Sanofi-Aventis Deutschland GmbH | Low pain penetrating member |
9186468, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
9226699, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Body fluid sampling module with a continuous compression tissue interface surface |
9248267, | Oct 04 2005 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
9261476, | May 20 2004 | Sanofi SA | Printable hydrogel for biosensors |
9314194, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Tissue penetration device |
9351680, | Oct 14 2003 | AUTO INJECTION TECHNOLOGIES LLC | Method and apparatus for a variable user interface |
9375169, | Jan 30 2009 | Sanofi-Aventis Deutschland GmbH | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
9386944, | Apr 11 2008 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for analyte detecting device |
9427532, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Tissue penetration device |
9498160, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method for penetrating tissue |
9560993, | Nov 21 2001 | Sanofi-Aventis Deutschland GmbH | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
9561000, | Dec 31 2003 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
9694144, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Sampling module device and method |
9724021, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
9795334, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for penetrating tissue |
9795747, | Jun 02 2010 | Pelikan Technologies, Inc | Methods and apparatus for lancet actuation |
9802007, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Methods and apparatus for lancet actuation |
9820684, | Jun 03 2004 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for a fluid sampling device |
9839386, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Body fluid sampling device with capacitive sensor |
Patent | Priority | Assignee | Title |
4169377, | Apr 17 1978 | Nalco Chemical Company | Quantity sensing system for a container |
5033300, | Jun 20 1989 | Murata Mfg., Co., Ltd. | Device for measuring displacement |
5148708, | May 08 1990 | Murata Mfg. Co., Ltd. | Liquid level sensor which prevents liquid absorption |
5226313, | Dec 15 1989 | MURATA MANUFACTURING CO , LTD | Body fluid excretion measurement apparatus for medical application |
5719556, | May 22 1995 | Liquid level sensor utilizing AC and resistance | |
5932799, | Jul 21 1997 | YSI Incorporated | Microfluidic analyzer module |
6748804, | Sep 15 1999 | Fraunhofer-Gesellschaft zur Foerderung der Angeandten Forschung E.V. | Microsensor for measuring the position of liquids in capillaries |
20020142477, | |||
20030060784, | |||
20030155237, | |||
EP537761, | |||
WO47322, | |||
WO2101343, | |||
WO249507, | |||
WO250534, | |||
WO3091717, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Mar 19 2004 | MOFFAT, JAMES | Lifescan, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 015889 | /0845 | |
Mar 19 2004 | MCNEILAGE, ALAN | Lifescan, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 015889 | /0845 | |
Mar 19 2004 | RODGERS, JAMES IAIN | Lifescan, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 015889 | /0845 | |
Mar 19 2004 | BOHM, SEBASTIAN | Lifescan, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 015889 | /0845 | |
Mar 22 2004 | RICHTER, TANJA | Lifescan, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 015889 | /0845 | |
Mar 26 2004 | LifeScan, Inc. | (assignment on the face of the patent) | / | |||
Mar 26 2004 | STEINE, MATTHIAS | Lifescan, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 015531 | /0764 | |
Oct 01 2018 | Cilag GmbH International | Lifescan IP Holdings, LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 050840 | /0006 | |
Oct 01 2018 | LIFESCAN INC | Cilag GmbH International | CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY LIST BY ADDING PATENTS 6990849 7169116 7351770 7462265 7468125 7572356 8093903 8486245 8066866 AND DELETE 10881560 PREVIOUSLY RECORDED ON REEL 050836 FRAME 0737 ASSIGNOR S HEREBY CONFIRMS THE ASSIGNMENT | 064782 | /0443 | |
Oct 01 2018 | Lifescan IP Holdings, LLC | BANK OF AMERICA, N A , AS COLLATERAL AGENT | SECURITY AGREEMENT | 047179 | /0150 | |
Oct 01 2018 | LIFESCAN SCOTLAND LTD | Cilag GmbH International | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 050839 | /0634 | |
May 19 2023 | Lifescan IP Holdings, LLC | BANK OF AMERICA, N A | FIRST LIEN PATENT SECURITY AGREEMENT | 063712 | /0430 | |
May 19 2023 | Lifescan IP Holdings, LLC | BANK OF AMERICA, N A | SECOND LIEN PATENT SECURITY AGREEMENT | 063740 | /0080 | |
Jun 27 2023 | BANK OF AMERICA, N A | Lifescan IP Holdings, LLC | RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT 3, 2018, REEL FRAME 047186 0836 | 064206 | /0176 | |
Jun 27 2023 | BANK OF AMERICA, N A | JANSSEN BIOTECH, INC | RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT 3, 2018, REEL FRAME 047186 0836 | 064206 | /0176 | |
Jun 27 2023 | BANK OF AMERICA, N A | JOHNSON & JOHNSON CONSUMER INC | RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT 3, 2018, REEL FRAME 047186 0836 | 064206 | /0176 |
Date | Maintenance Fee Events |
Jul 01 2009 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Mar 13 2013 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Jul 24 2017 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
Date | Maintenance Schedule |
Jan 31 2009 | 4 years fee payment window open |
Jul 31 2009 | 6 months grace period start (w surcharge) |
Jan 31 2010 | patent expiry (for year 4) |
Jan 31 2012 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jan 31 2013 | 8 years fee payment window open |
Jul 31 2013 | 6 months grace period start (w surcharge) |
Jan 31 2014 | patent expiry (for year 8) |
Jan 31 2016 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jan 31 2017 | 12 years fee payment window open |
Jul 31 2017 | 6 months grace period start (w surcharge) |
Jan 31 2018 | patent expiry (for year 12) |
Jan 31 2020 | 2 years to revive unintentionally abandoned end. (for year 12) |